(Press-News.org) Contact information: Daphne Watrin
d.watrin@iospress.nl
31-206-883-355
IOS Press
Corticosteroid added to standard treatment improves eyesight in patients with sudden vision loss
According to study published in Restorative Neurology and Neuroscience
Amsterdam, NL, November 19, 2013 – Nonarteritic anterior ischemic optic neuropathy (NAION) is one of the leading causes of sudden and irreversible loss of vision in older adults. In a prospective randomized trial of 60 patients with NAION, investigators have shown that the addition of the corticosteroid fluocortolone (FC) to standard therapy significantly improves both short- and long-term visual acuity, especially when given soon after the onset of symptoms. Their results are published in Restorative Neurology and Neuroscience.
NAION, a disabling condition which can affect both eyes in up to 19% of cases within 5 years, occurs in about 2.3 per 100,000 adults over the age of 50. Incidence increases steadily with age. Patients have few well-tested or effective treatment options beyond the standard administration of pentoxifylline (PTX), which is thought to improve visual acuity by improving the microcirculation in oxygen-deprived optic nerve tissue. No current treatment reverses or limits the course of the disease. The goal of the current study was to see whether adding a steroid to PTX could improve vision, perhaps by reducing edema or inflammation.
Researchers from the Institute of Experimental Ophthalmology, University of Münster, Germany, studied 55 patients diagnosed with NAION who had developed sudden loss of visual acuity less than 3 days before the initial consultation. These patients were treated with PFX as well as adjunctive therapy with FC during the first 2-3 months (which was gradually tapered). The control group received only PFX.
Investigators found that PFX alone had no significant beneficial effects on either visual acuity (as measured as Best Corrected Visual Acuity, BCVA) or visual field after 3 days and 6 months of treatment. However, adding FC significantly boosted outcomes: those receiving FC were more likely to experience improvement and less likely to have worsened visual acuity. Progress was even more pronounced after 6 months of therapy. More than two thirds of NAION patients treated with the combination therapy had better long-term vision compared to only 14% of those only treated with PFX.
The authors explain why FC apparently benefits those who have less severe visual loss. "NAION is caused by ischemia of the optic nerve head.... This restriction of blood supply, depending upon its degree, results in primary irreversible loss of retinal ganglion cells (RGC) and secondary delayed RGC loss related to subsequent optic-disc edema," says Verena Prokosch, PhD, Dr. med., Institute of Experimental Ophthalmology.
"Corticosteroids do not appear to reduce primary cell death, explaining the lack of benefit of FC therapy in patients with a BCVA score worse than 0.05. This may not be the case for patients with moderate BCVA loss who suffer secondary RGC loss due to optic-nerve swelling, revealing a possible therapeutic window for FC," explains co-author Solon Thanos, MD, Prof. Dr. med. Dr. rer.nat., Institute of Experimental Ophthalmology. Prof. Dr. Thanos suggests that the pronounced long-term effect of FC on visual acuity found in the study could be attributed to early and prolonged treatment at a dose higher than previously tested.
### END
Corticosteroid added to standard treatment improves eyesight in patients with sudden vision loss
According to study published in Restorative Neurology and Neuroscience
2013-11-19
ELSE PRESS RELEASES FROM THIS DATE:
Blood test accurately diagnoses concussion and predicts long term cognitive disability
2013-11-19
Blood test accurately diagnoses concussion and predicts long term cognitive disability
Penn medicine researchers discover that high levels of a protein in blood after traumatic brain injury correlate with brain tissue damage
PHILADELPHIA ...
'GUMBOS' promise new drugs and electronics: American Chemical Society Prized Science video
2013-11-19
'GUMBOS' promise new drugs and electronics: American Chemical Society Prized Science video
A group of nanoparticles called "GUMBOS" is as varied as their culinary namesake implies, with a wide range of potential applications from cancer therapy to sensors. ...
Smartphone apps lack proven strategies to help smokers quit
2013-11-19
Smartphone apps lack proven strategies to help smokers quit
WASHINGTON, DC (November 19, 2013)—An estimated 11 million smokers in the United States own a smartphone and increasingly they're turning to apps ...
Origin of species: Protein imbalances doom hybrids
2013-11-19
Origin of species: Protein imbalances doom hybrids
Why do crosses between closely related species fail to produce fertile hybrids? A new study led by Professor Axel Imhof of Ludwig-Maximilians-Universitaet (LMU) in Munich shows that differences ...
Scientists nearing forecasts of long-lived wildfires' paths
2013-11-19
Scientists nearing forecasts of long-lived wildfires' paths
New computer modeling technique offers promise of continually updated predictions
Scientists have developed a new computer modeling technique that for the first time offers the promise of continually-updated ...
UT Dallas computer scientists create 3-D technique
2013-11-19
UT Dallas computer scientists create 3-D technique
3-D imaging technique utilizes famous mathematician's theory
UT Dallas computer scientists have developed a technique to create 3-D images that finds practical applications of a theory created by ...
New study determines more accurate method to date tropical glacier moraines
2013-11-19
New study determines more accurate method to date tropical glacier moraines
Dartmouth-led research may alter previous interpretations of climate's impact on equatorial glaciers
A Dartmouth-led team has found a more accurate method to determine the ages of boulders ...
Study finds youth prefer and benefit more from rapid point-of-care HIV testing
2013-11-19
Study finds youth prefer and benefit more from rapid point-of-care HIV testing
TORONTO, Nov. 19, 2013 – Youth prefer, accept and receive HIV results more often when offered rapid finger prick or saliva swab tests rather than traditional blood tests according ...
Study: Ureteral injury during robot-assisted prostate surgery
2013-11-19
Study: Ureteral injury during robot-assisted prostate surgery
DETROIT – There may be warning signs to help surgeons avoid damaging part of the urinary system during robot-assisted surgical removal of prostate cancer, ultimately preventing the expense of additional ...
Tropical Cyclone 04B forms in northern Indian Ocean
2013-11-19
Tropical Cyclone 04B forms in northern Indian Ocean
The fourth tropical cyclone of the Northern Indian Ocean season formed and is headed for landfall in a couple of days in southeastern India. NASA's TRMM satellite saw broken bands of thunderstorms with moderate ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Corticosteroid added to standard treatment improves eyesight in patients with sudden vision lossAccording to study published in Restorative Neurology and Neuroscience